ELECTROCHEMICAL BIOSENSOR USING RECOMBINANT PROTEIN FOR COVID-19 DETECTION
World Health Organization (WHO) has declared coronavirus disease 2019 (COVID-19) as a pandemic because of its rapid spread throughout the world. Various efforts were made to suppress the spread of the virus by conducting tests to prevent transmission from infected individuals. Currently, reverse...
Saved in:
Main Author: | |
---|---|
Format: | Final Project |
Language: | Indonesia |
Online Access: | https://digilib.itb.ac.id/gdl/view/58388 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Institut Teknologi Bandung |
Language: | Indonesia |
Summary: | World Health Organization (WHO) has declared coronavirus disease 2019 (COVID-19) as a
pandemic because of its rapid spread throughout the world. Various efforts were made to
suppress the spread of the virus by conducting tests to prevent transmission from infected
individuals. Currently, reverse transcriptase polymerase chain reaction (RT-PCR) is the
standard test for detecting COVID-19. However, this method is expensive and requires medical
personnel, so there is a need to develop portable, accurate and affordable diagnostic tests. To
answer this problem, the author developed a biosensor using electrodes modified with gold
nanoparticles (AuNP).
This study used single-chain fragment variable (scFv) as a bioreceptor immobilized on a
AUNP-modified screen-printed carbon electrode. scFv has the advantage of having the same
specificity as intact antibody despite its smaller size. The performance of the biosensor was
evaluated by measuring cyclic voltammetry (CV), differential pulse voltammetry (DPV), and
electrochemical impedance spectroscopy (EIS) in ferrocyanide solution as a redox probe.
AuNP plays an important role in increasing the conductivity of the electrode. CV measurements
on AuNP-modified electrodes showed a significant increase in peak oxidation current.
Meanwhile, the charge transfer resistance (Rct) decreased significantly in the EIS
measurement. The biosensor was able to detect the receptor-binding domain (RBD) of severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In addition, the biosensor showed
good selectivity when it is tested with infectious bronchitis virus (IBV) because there was no
change in Rct.
|
---|